Ikarian Capital »

Journey Med Corp shares owned by Ikarian Capital

Quarter-by-quarter ownership of Journey Med Corp (DERM) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Journey Med Corp

Tip: Access up to 7 years of quarterly data

All positions including Journey Med Corp held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Journey Med Corp by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.9M 251k 7.71

More positions owned by Ikarian Capital

Cidara Therapeutics Com New (CDTX)
Spdr Series Trust State Street Spd Put Option (XBI)
Amgen (AMGN)
Terns Pharmaceuticals (TERN)
Abivax Sa Sponsored Ads (ABVX)
Harrow Health (HROW)
Rapt Therapeutics Com New (RAPT)
Cytokinetics Com New (CYTK)
Jazz Pharmaceuticals Call Call Option
Soleno Therapeutics (SLNO)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Maze Therapeatics (MAZE)
Omeros Corporation Call Option (OMER)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)

View all positions for Ikarian Capital

Top funds holding Journey Med Corp

Tang Capital Management
Daniel D. Thurber
Opaleye Management
Vanguard Group
BlackRock
Pale Fire Capital SE
Summit Financial
Essex Investment Management
Geode Capital Management
UBS Group
Ikarian Capital
Renaissance Technologies
American Financial Group
State Street Corporation
Sheets Smith Investment Management

View all funds holding Journey Med Corp